TALPHERA, INC. Payments to Acquire Short-term Investments
TALPHERA, INC. (TLPH) reported Payments to Acquire Short-term Investments of $17.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-12
- TALPHERA, INC. payments to acquire short-term investments for the quarter ending 2026-06-30 was $0.00.
- TALPHERA, INC. payments to acquire short-term investments for the quarter ending 2026-03-31 was $17.24M.
- TALPHERA, INC. payments to acquire short-term investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. payments to acquire short-term investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. payments to acquire short-term investments for fiscal 2024 was $4.98M, a 36.37% increase from fiscal 2023.
- TALPHERA, INC. payments to acquire short-term investments for fiscal 2023 was $3.65M, a 53.56% decline from fiscal 2022.
- TALPHERA, INC. payments to acquire short-term investments for fiscal 2022 was $7.86M.
- TALPHERA, INC. payments to acquire short-term investments for fiscal 2020 was $44.61M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $17.24M 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $17.24M 10-Q · filed 2026-05-13 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $749.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $749.00K derived: sum of 3 quarters · filed 2025-03-31 | $4.98M 10-K · filed 2025-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $749.00K derived: sum of 2 quarters · filed 2024-11-13 | $4.98M 10-Q · filed 2024-11-13 | $8.63M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $749.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $4.98M 10-Q · filed 2024-08-14 | $8.63M derived: sum of 3 quarters · filed 2025-05-14 | $8.63M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $4.23M 10-Q · filed 2025-05-14 | $7.88M derived: sum of 2 quarters · filed 2025-05-14 | $7.88M derived: sum of 3 quarters · filed 2025-05-14 | $7.88M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.65M derived: sum of 2 quarters · filed 2025-03-31 | $3.65M derived: sum of 3 quarters · filed 2025-03-31 | $3.65M 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $492.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $492.00K derived: sum of 3 quarters · filed 2024-08-14 | $492.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $492.00K derived: sum of 2 quarters · filed 2024-05-14 | $492.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.69M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $492.00K derived: sum of 2 quarters · filed 2024-03-06 | $1.69M derived: sum of 3 quarters · filed 2024-03-06 | $7.86M 10-K · filed 2024-03-06 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.19M derived: sum of 2 quarters · filed 2023-11-14 | $7.37M 10-Q · filed 2023-11-14 | $23.96M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $7.37M 10-Q · filed 2023-08-10 | $23.96M derived: sum of 3 quarters · filed 2023-08-10 | $39.63M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $6.17M 10-Q · filed 2023-05-10 | $22.77M derived: sum of 2 quarters · filed 2023-08-01 | $38.43M derived: sum of 3 quarters · filed 2023-08-01 | $52.19M derived: sum of 4 quarters · filed 2023-08-01 |
| 2021-12-31 | $16.59M derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | $32.26M derived: sum of 2 quarters · filed 2023-08-01 | $46.02M derived: sum of 3 quarters · filed 2023-08-01 | $70.46M 8-K · filed 2023-08-01 |
| 2021-09-30 | $15.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $29.43M derived: sum of 2 quarters · filed 2022-11-14 | $53.87M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $13.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $38.20M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $24.44M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $44.61M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |